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Summary: Small study effects occur when smaller studies show different, often larger, treatment effects than large
ones, which may threaten the validity of systematic reviews and meta-analyses. The most well-known reasons for
small study effects include publication bias, outcome reporting bias and clinical heterogeneity. Methods to account
for small study effects in univariate meta-analysis have been extensively studied. However, detecting small study
effects in a multivariate meta-analysis setting remains an untouched research area. One of the complications is that
different types of selection processes can be involved in the reporting of multivariate outcomes. For example, some
studies may be completely unpublished while others may selectively report multiple outcomes. In this paper, we
propose a score test as an overall test of small study effects in multivariate meta-analysis. Two detailed case studies
are given to demonstrate the advantage of the proposed test over various naive applications of univariate tests in
practice. Through simulation studies, the proposed test is found to retain nominal Type I error rates with considerable
power in moderate sample size settings. Finally, we also evaluate the concordance between the proposed test with the
naive application of univariate tests by evaluating 44 systematic reviews with multiple outcomes from the Cochrane
Database.
Key words: Comparative effectiveness research; Composite likelihood; Outcome reporting bias; Publication bias;
Small study effect; Systematic review.
This paper has been submitted for consideration for publication in Biometrics
This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting,
pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article
as doi: 10.1111/biom.13342
A
cc
ep
te
d
A
rt
ic
le
This article is protected by copyright. All rights reserved.
Testing small study effects in multivariate meta-analysis 1
1. Introduction
Meta-analysis is a statistical procedure that combines the results of multiple scientific studies.
In meta-analysis, small study effects (SSE) is a well-known critical and challenging issue
that may threaten the validity of the results (Sutton et al., 2000). “Small-study effects”
is a generic term for the phenomenon that smaller studies sometimes show different, often
larger, treatment effects than large ones (Sterne and Egger, 2001). One of the most well-
known reason for SSE is publication bias (PB), in which case the chance of a small study
being published does not depend on its quality, but on its effect size, significance or direction.
A possible reason is that authors tend to report significant or positive results or journals
tend to publish studies with significant or positive results. Besides PB, outcome reporting
bias (ORB) and clinical heterogeneity (i.e. variability in the participants, interventions and
outcomes) in small studies are also important sources for SSE. It is worth mentioning that
small trials or the large effect sizes coming from small studies themselves are not problematic,
and provide valuable information. However, selective publication of the results from smaller
studies may be more common than those from larger studies.
SSE (including PB) is arguably the greatest threat to the validity of meta-analysis (Schwarzer
et al., 2015). Erroneous conclusions can arise from a meta-analysis if SSE is not properly
accounted for. For example, conclusions from several meta-analyses were later found to be
contradicted by mega-trials (Egger and Smith, 1995). In the last two decades, a great deal of
effort has been devoted to better reporting protocols, risk of bias evaluation, and statistical
methods to detect and correct for SSE based on reported studies (Bu¨rkner and Doebler,
2014).
Among the many statistical methods on this issue, funnel plots have been commonly used
to study SSE. Statistical tests based on funnel plot symmetry have been developed, including
the rank correlation test (Begg and Mazumdar, 1994) and regression-based tests (Egger et al.,
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1997; Harbord et al., 2006). Using the symmetry of funnel plots, Duval and Tweedie (2000)
further developed the nonparametric “Trim and Fill” method for imputing missing studies in
a meta-analysis. Recently, Lin and Chu (2018) proposed a method to quantify the magnitude
of publication bias in univariate meta-analysis based on the skewness of the standardized
deviates. Similar to Egger’s regression test, the measure proposed by Lin and Chu describes
the asymmetry of the distribution of individual studies.
Multivariate meta-analysis (MMA), which jointly analyzes multiple and possibly correlated
outcomes, has recently received a great deal of attention (Jackson et al., 2011a). By borrowing
information across outcomes, MMA improves estimation of both pooled effects and between-
study variances. However, to the best of our knowledge, statistical tests that quantify the
evidence of SSE for multivariate meta-analysis have not been developed. In fact, there are
several unique challenges in MMA that need to be properly addressed in developing a sensible
test to study SSE in MMA.
The first challenge comes from various scenarios of SSE. Unlike univariate meta-analysis,
some studies may have only part of their outcomes selectively reported, known as outcome
reporting bias (ORB) (Chan and Altman, 2005). More recently, an investigation of the
impact of ORB in reviews of rheumatoid arthritis from the Cochrane Database of Systematic
Reviews (hereinafter refer to as the “Cochrane Database”) suggests that ORB has the
potential to affect the conclusion in meta-analysis (Frosi et al., 2015). Therefore, a measure to
quantify SSE needs to include both PB and ORB scenarios. The second challenge is to fully
account for the multivariate nature of MMA. With multiple outcomes, a common practice
is to apply a univariate test, such as the Egger’s test, to each of outcomes and report PB
for outcomes with small p-values (Kavalieratos et al., 2016). The problem of multiple testing
is often ignored, which may cause excessive false positive findings. In the effort of studying
SSE in MMA, we shall aim to apply the strength of MMA by combining information across
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outcomes. The third challenge is that within-study outcome correlations, typically required
by MMA methods, are often not reported and are difficult to obtain even on request (Riley
et al., 2008; Chen et al., 2015). As a consequence, the standard likelihood involves unknown
within-study correlations, which makes the traditional likelihood based tests (e.g., Wald,
score and likelihood ratio tests) not applicable.
In this paper, we propose a score test to study the overall evidence of SSE. To the best
of our knowledge, this is the first test for SSE in MMA setting. The proposed test has
the following properties. First, by combining evidence of SSE across multiple outcomes,
the proposed test can detect SSE due to PB and/or ORB. Secondly, by jointly modeling
multivariate outcomes, the proposed test fully accounts for the multivariate nature of MMA,
which avoids the separate investigations of individual outcomes. We demonstrate the superior
power of the proposed test as compared to the simple procedure of separate investigation
of outcomes. Furthermore, the proposed test is based on a pseudolikelihood of MMA in the
same spirit as Chen et al. (2014). A key advantage is that within-study correlations are
not required. Lastly, the test statistic has a closed-form formula and a simple approximated
distribution.
2. Method
In this section, we introduce notation for the multivariate random-effects meta-analysis and
review the existing funnel-plot-based methods for detecting SSE, including Egger’s regression
test and two of its variations, Begg’s rank test and the Trim and Fill method.
2.1 Notations for multivariate random-effects meta-analysis
We consider a meta-analysis with m studies where a common set of J outcomes are of
interest. For the ith study, let Yij and sij denote, respectively, the summary measure for
the jth outcome and the associated standard error, both assumed known, for i = 1, . . . ,m
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and j = 1, . . . , J . Each summary measure Yij is an estimate of the true effect size θij. To
account for heterogeneity in effect size across studies, we assume θij to be independently
drawn from a common distribution with overall effect size βj and between-study variance τ
2
j ,
j = 1, . . . , J . Under the assumption of a normal distribution for Yij and θij, a multivariate
random-effects model is often taken to be

Yi1
...
YiJ
 ∼ N


θi1
...
θiJ
 ,∆i
 , ∆i =

s2i1 . . . si1siJρWi(1J)
...
. . .
...
siJsi1ρWi(1J) . . . s
2
iJ
 , (1)

θi1
...
θiJ
 ∼ N


β1
...
βJ
 ,Ω
 , Ω =

τ 21 . . . τ1τJρB(1J)
...
. . .
...
τJτ1ρB(1J) . . . τ
2
J
 , (2)
where ∆i and Ω are J × J study-specific within-study and between-study covariance matri-
ces, respectively, and ρWi(jk) and ρB(jk) are the respective within-study and between-study
correlations between the jth and kth outcomes (Jackson et al., 2011a). When the within-
study correlations ρWi(jk) are known, inference on the overall effect sizes (β1, . . . , βJ) can be
based on the marginal distribution of (Yi1, . . . , YiJ), i.e.,

Yi1
...
YiJ
 ∼ N


β1
...
βJ
 ,Vi
 , Vi = ∆i + Ω. (3)
We note that the variance of Yij is partitioned into two parts (s
2
ij and τ
2
j ) as in analysis of vari-
ance (ANOVA) for univariate random-effects models, and the covariance is also partitioned
into two parts as the sum of within- and between-study covariances, i.e., cov(Yij, Yik) =
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sijsikρWi(jk) + τjτkρB(jk). However, study-specific within-study correlations ρWi(jk) among
multiple outcomes are generally unknown (Riley et al., 2008; Chen et al., 2014).
2.2 A score test for multivariate meta-analysis
In this subsection, we propose a score test for SSE under MMA. The proposed test can be
considered as a multivariate extension of Egger’s regression test, which fully accounts for
the multivariate nature of MMA, and does not require within-study correlations. We refer
to our test as the Multivariate Small Study Effect Test (MSSET) hereinafter. Specifically,
we calculate each component of the pseudolikelihood (Gong and Samaniego, 1981) using the
estimated residuals in the regression model of the univariate Egger’s test and then employ
the idea of composite likelihood (Lindsay, 1988) to combine individual pseudolikelihoods
together. For the jth outcome of the ith study, define the standardized effect size as SNDij =
Yij
(
s2ij + τ
2
j
)−1/2
and the precision as Pij =
(
s2ij + τ
2
j
)−1/2
. We have
SNDij = aj + bjPij + εij, (4)
where aj is the intercept that measures the asymmetry, bj is the slope indicating the size
and direction of effect, εij is a standard normal random variable. Let τ˜
2
j denote a consistent
estimator of τ 2j (e.g., a moment estimator). By substituting τ˜
2
j into model (4), we obtain the
log pseudolikelihood
logLjp(aj, bj) = −
1
2
m∑
i=1
(S˜NDij − aj − bjP˜ij)2, (5)
where S˜NDij and P˜ij are simply SNDij and Pij with τ
2
j replaced by τ˜
2
j . We note here
that the regression coefficients (aj, bj) (in particular aj) are parameters of interest, while
the heterogeneity τ 2j is a nuisance parameter. Replacing the nuisance parameter by its
estimate can reduce its impact and offer a simple inference procedure. Such an idea was
originally proposed by Gong and Samaniego (1981), where the uncertainty associated with
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the estimated nuisance parameters is properly accounted for, and it was later studied by
Liang and Self (1996) and Chen and Liang (2010) in various settings.
To combine the signal for SSE from multivariate outcomes, we propose the following
pseudolikelihood by synthesizing individual pseudolikelihoods across outcomes:
logLp(a,b) =
J∑
j=1
logLjp(aj, bj), (6)
where a = (a1, . . . , aJ)
T and b = (b1, . . . , bJ)
T . By simply adding together the log pseudo-
likelihoods for the various outcomes, we avoid the use of within-study correlations. This idea
is similar to the composite likelihood (Lindsay, 1988) or independence likelihood (Chandler
and Bate, 2007), where (weighted) likelihoods are multiplied together whether or not they
are independent. An important distinction here is that each component in logLp(a,b) is a
pseudolikelihood (instead of a likelihood), and its score function is not an unbiased estimating
equation. Using a similar argument as in the proofs of Lemma 2.1 and Theorem 2.2 in Gong
and Samaniego (1981), for the jth outcome, we have shown the asymptotic consistency
and normality of the maximum pseudolikelihood estimator in Appendices A and B of the
Supporting Information.
With the pseudolikelihood in equation (6), testing SSE in MMA can be carried out by
simply testing H0 : a = 0, where a = (a1, . . . , aJ)
T . We propose the following procedure,
where the calculation at each step has a closed-form expression.
(1) Calculation of the pseudo-score function
The maximum pseudolikelihood estimator under aj = 0 can be calculated as
b˜j(0) =
(
m∑
i=1
P˜
2
ij
)−1( m∑
i=1
S˜NDijP˜ij
)
.
The pseudo-score function w.r.t. a under the null can be calculated as Ua
{
0, b˜(0), τ˜2
}
=(∑m
i=1 S˜NDi1 − R1, . . . ,
∑m
i=1 S˜NDiJ − RJ
)T
, where Rj = b˜j(0)
∑m
i=1 P˜ij. For notation
simplicity, we use Ua
{
0, b˜(0)
}
to denote Ua
{
0, b˜(0), τ˜2
}
hereafter.
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(2) Calculation of information matrices
The negative Hessian of the log pseudolikelihood function evaluated at (0, b˜(0)) is
calculated as
I0 =
 I0aa I0ab
I0ab
T I0bb
 ,
where I0aa = diag(m, . . . ,m) is a J-dimensional diagonal matrix with m as its diagonal
elements, I0ab = diag(
∑m
i=1 Pi1, . . . ,
∑m
i=1 PiJ) is a J-dimensional diagonal matrix with∑m
i=1 Pij as its jth element, and I0bb = (
∑m
i=1 P
2
i1, . . . ,
∑m
i=1 P
2
iJ) is a J-dimensional
diagonal matrix with
∑m
i=1 P
2
ij as its jth element. The J × J submatrix of the inverse of
I0 with respect to a, denoted by I
aa
0 , can be calculated as
(
I0aa − I0aaI−10bbI0ab
)−1
.
(3) Calculation of the test statistic
Let Σaa denote the asymptotic variance of
√
m(â− a0). The calculation of Σaa requires
properly accounting for the additional uncertainty in τ˜ 2, as we described in Appendix C
of the Supporting Information. Let λ denote the arithmetic mean of the eigenvalues of
(Iaa0 )
−1Σaa. The proposed MSSET test is constructed by
MSSET =
(
mλ
)−1
Ua
{
0, b˜(0)
}T
I0
aaUa
{
0, b˜(0)
}
. (7)
The test statistic is compared with the χ2J distribution to obtain a p-value.
A proof of the asymptotic distribution of the score test is provided in Appendix C of
the Supporting Information. We note that instead of constructing the test following the
traditional score test for composite likelihood (e.g., the pseudo-score statistics defined on
page 193 in Molenberghs and Verbeke (2005)), the above test is constructed for better
computational stability. Finally, the proposed test reduces to the traditional Egger’s test
for univariate meta-analysis when the number of outcomes is one (i.e., J = 1). The above
steps for obtaining the MSSET and p-value will be illustrated in Section 4.1. In addition to
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MSSET multivariate meta-analysis for continuous outcomes, we also developed a modified
version of MSSET for binary outcomes. The details are provided in Appendix D of the
Supporting Information.
3. Two case studies
In this section, we consider two case studies: 1) structured telephone support or non-invasive
tele-monitoring for patients with heart failure and 2) prognostic value of MYCN and Chro-
mosome 1p in patients with neuroblastoma.
3.1 Structured telephone support or non-invasive tele-monitoring for patients with heart
failure
Heart failure is a complex, debilitating disease. To improve clinical outcomes, and reduce
healthcare utilization, specialized disease management programs are conducted, such as
structured telephone support and non-invasive home telemonitoring. Over the last decade,
trials have been conducted to examine the effects of these programs. To compare structured
telephone support or non-invasive home tele-monitoring interventions with standard practice,
Inglis et al. (2016) conducted a systematic review including 41 randomized clinical trials.
Primary outcomes included all-cause mortality, and both all-cause and heart failure-related
hospitalizations. Other outcomes included length of stay, health-related quality of life, heart
failure knowledge and self-care, acceptability and cost.
We revisit the systematic review conducted by Inglis et al. (2016), and use the primary
outcome (all-cause mortality) and the secondary outcome (mental quality of life) to illustrate
the proposed method. We analyze the 35 trials that reported either of the two outcomes.
Among the 35 trials, 11 reported both outcomes; 34 reported the primary; and 12 reported
the secondary outcome.
[Figure 1 about here.]
A detailed step-by-step illustration of the calculation of proposed MSSET is provide in
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Appendix E of the Supporting Information. The upper panel in Figure 1 displays the funnel
plots of all-cause mortality and mental quality of life of 35 trials. The funnel plots of both all-
cause mortality and quality of life suggest severe asymmetry. Such an observation is confirmed
by univariate tests of SSE (Egger’s test). When we apply Eggers test to the two outcomes
separately, both are marginally significant (p=0.09 and 0.06). But after Bonferroni correction,
both are not significant. In contrast, the proposed test yields statistically significant result
with smaller p-values (p=0.03). We use this example to highlight a limitation of univariate
tests: the loss of power after adjusting for multiple testing. In contrast, the proposed MSSET
test is better in identifying SSE by combining signals of SSE from multiple outcomes.
3.2 MCYN and Chromosone 1p in patients with neuroblastoma
Neuroblastoma, a type of cancer that starts in early nerve cells, is a common extracranial
solid tumor of childhood. Studies have been conducted to assess whether amplified levels
of MYCN and deletion of chromosome 1p, Ch1p, are associated with survival outcomes in
children with neuroblastoma. Jackson et al. (2011b) conducted a meta-analysis to examine
the association of the two factors (MYCN and Chromosome 1p) with overall and disease-free
survival. Seventy-three studies assessing the prognostic values of MYCN and Chromosome
1p, in patients with neuroblastoma are included in this meta-analysis. Up to four estimates
of effect are provided by the individual studies, including an estimated unadjusted log hazard
ratio of survival, either of the high relative to the low level group of MYCN, or Chromosome
1p deletion to its presence.
We study the SSE for overall survival and disease free survival using Egger’s test and
the proposed MSSET test. The lower panel in Figure 1 displays the funnel plots of the two
outcomes. For the overall survival, we observe a certain degree of asymmetry, while for the
disease-free survival, we do not observe such evidence. Similarly, applying univariate methods
for SSE to outcomes separately only lead to the detection of SSE for overall survival (p=0.01
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and 0.58). The proposed MSSET test suggests a statistically significant evidence of overall
SSE for bivariate outcomes (p=0.02).
4. Simulation studies and an empirical evaluation using 44 systematic reviews
In this section, we evaluate the performance of the proposed MSSET test through fully
controlled simulation studies, and study the empirical impact of our new MSSET.
4.1 Simulation studies
In our simulation studies, we compare the proposed MSSET test with the commonly used
Egger’s regression test and Begg’s rank test. The data are generated from MMA with a
common set of two outcomes as specified by model (1). To cover a wide spectrum of scenarios,
we vary the values of several factors that are considered important in practice: 1) To reflect
the heterogeneity in the standard error of the summary measure across studies, we sample
s2ij from the square of the distribution N(0.3, 0.5), which leads to a mean value of 0.33 for s
2
ij.
2) The size of the within-study variation relative to the between-study variation may have
a substantial impact on the performance of the methods. To this end, we let the between-
study variances τ 21 = τ
2
2 range from 0.1 to 2 to represent the random-effects model with
relatively small to large random effects. 3) For within-study and between-study correlations,
we consider ρWi to be constant with value −0.5, 0, or 0.5 and ρB to be constant with value
−0.5, 0, or 0.5. 4) The number of studies n is set to 10, 25, 50, or 100 to represent meta-
analysis of small to large numbers of studies. We consider the Type I error setting where the
selection (i.e., the decision of whether to publish a particular study or report a particular
outcome) does not depend on the effect sizes. We also consider the power settings where
the selection depends on the effect sizes. We conduct 5000 simulations for the Type I error
setting and 1000 simulations for the power settings. For the power settings, in order to obtain
n published studies, we follow three steps: 1) N studies are simulated, where N is an integer
greater than n (here we choose N = 3n to ensure there are enough studies before selection);
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2) studies are excluded based on four different selection scenarios described in the following
paragraph; and 3) n studies are sampled randomly from those that remain after the previous
step.
4.1.1 Selection model scenarios. To evaluate the performance of MSSET, it is critical to
design and cover a wide range of publication/reporting scenarios. We consider four different
scenarios for two types of SSE, including scenarios where studies are completely missing
(Scenario C1, C2, and C3), and scenarios where studies are partially missing (Scenario P).
For Scenarios C1–C3, the probability of a study being published depends on the p-values of
both effect sizes of this study. For example, as shown in the upper left panel of Figure 2, a
study is published if and only if the p-values of both effect sizes are less than 0.05. Although
Scenarios C2 and C3 may be more common in practice, we include Scenario C1 as it was
usually considered in the literature as a benchmark for sanity check of a procedure (Bu¨rkner
and Doebler, 2014). For Scenario P (P stands for partial reporting), as visualized in the
lower-right panel of Figure 2, the probability of an outcome being reported depends on the
p-value of its effect size. A brief description, as well as the data of obtaining this selection
model are provided in Appendix F of the Supporting Information.
[Figure 2 about here.]
4.1.2 Simulation results. Table 1 summarizes the Type I errors rates at the 10% nominal
level of the tests under comparison. The proposed MSSET test controls the Type I error rates
well in all settings. The Egger’s regression test for one outcome only (Egger1) or two outcomes
separately with Bonferroni correction (EggerBON) have slightly inflated Type I error rates
when the sample size is small (n = 10), while other adjustment methods proposed by Holm
(1979), Hochberg (1988), Benjamini and Hochberg (1995), and Benjamini et al. (2001) tend
to produce conservative Type I error rates. We observe that the Type I error rates of Begg’s
rank test are very conservative when the sample size is relatively small but inflated when it is
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relatively large. This observation is consistent with the literature, where investigators report
that Begg’s rank test does not perform well in controlling Type I errors rates (Bu¨rkner and
Doebler, 2014).
[Table 1 about here.]
[Figure 3 about here.]
Figure 3 summarizes the power of the tests under comparison. Clearly, the proposed MSSET
test is the most sensitive under all the settings considered. Egger’s regression test on one
outcome (Egger1) and those on two outcomes with Bonferroni correction (EggerBON) and
Benjamini & Hochberg correction (EggerBH) have substantial power loss compared with the
proposed MSSET. There are several additional interesting findings from Figure 3:
1) For Scenarios C1–C3, we observe non-monotonic trends for the MSSET test and Egger’s
regression test. A possible explanation for this non-monotonicity is due to the fact that both
the MSSET test and Egger’s regression test assume the random-effects model and require
the estimation of the between-study variance τ 2. However, when the between-study variance
is close to zero, a fixed-effect model is more suitable than a random-effects model. Therefore,
these two tests have lower power as heterogeneity is very small, as a consequence of lack of
good fit assumed for the random-effect meta-analysis model.
2) Unlike in Scenarios C1–C3, the power curve in Scenario P is increasing. One possible
explanation is that this scenario allows selective reporting of parts of multiple outcomes.
Because the proposed test combines signals of SSE across multiple outcomes, the number of
studies required to identify the same degree of heterogeneity is smaller than that required
for the other scenarios.
3) We observe that there is a decreasing trend in power from Scenario C1 to Scenario C3
for all tests under comparison. This indicates that it is easier to detect SSE when selectivity
is greater.
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In addition, we evaluate the performance of the modified version of MSSET using smoothed
within-study variance for binary outcomes as described in Appendix G. The observation is
consistent with the literature, in that the correlated effect size and its variance will lead to
false positive testing results of SSE. The MSSET and Egger’s tests using smoothed variance
control the Type I errors rates better than those using naive variances.
4.2 An empirical evaluation using 44 systematic reviews from the Cochrane Database
To evaluate the practical impact of MSSET, we compare the results of MSSET with the
results from univariate tests of SSE by applying MSSET and the Egger’s test to a large
number of comparable meta-analyses obtained from the Cochrane Database of Systematic
Reviews, an online collection of regularly updated systematic reviews and meta-analyses of
medical studies. We do not include the Begg’s test for comparison, since our simulation study
in the previous session indicated that Begg’s rank test does not perform well in controlling
Type I error rates. We extracted 5320 out of 11401 available reviews from the database
before July 2015 (6081 files were corrupt). Among these records, we identified 1675 meta-
analyses that compare treatment to placebo or no treatment. The following criteria were
then applied: a) the number of studies in a meta-analysis must be at least 10; b) all studies
in a meta-analysis must contain a common set of two different outcomes; and c) in any
meta-analysis, at least one study should report both outcomes. Similar criteria have been
used in the literature (Trikalinos et al., 2014). After imposing the above quality control, we
obtained 44 meta-analyses with bivariate outcomes.
We compare the results from MSSET with the results of the univariate Egger’s test on
bivariate outcomes separately. Specifically, for each meta-analysis, we apply MSSET, the
Egger’s test on outcome 1 (Egger1), and the Egger’s test on outcome 2 (Egger2). We then
dichotomize the p-value at the level of 0.10, for MSSET test, Egger1 and Egger2. In addition,
we use Bonferroni correction to combine the results from Egger’s test of bivariate outcomes
(EggerBonferroni). We cross-tabulate the dichotomized results, comparing the MSSET test
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results with one of the univariate tests. Table 2 shows 2×2 tables of the number of meta-
analyses that identified SSE via the MSSET test, versus one of the three Egger’s tests.
Among the 44 meta-analyses considered in the analysis, MSSET has identified 7 (16%)
meta-analyses with SSE at the significance level of 0.10. Egger’s regression test has identified
4 (9%) meta-analyses having SSE for both outcome 1 and outcome 2. For both outcomes
with Bonferroni correction, Egger’s regression test and Begg’s rank test has identified 6
(14%) meta-analyses having SSE. The percentage of SSE identified by the MSSET test is
the highest among all tests, which is consistent with the simulation results showing that the
MSSET test is the most powerful among all tests under comparison. In addition, MSSET is in
a larger concordance with the EggerBonferroni test, by combining signals from both outcomes.
In summary, this “meta-meta” analysis of 44 reviews from the Cochrane Database demon-
strates the practical implications of MSSET by comparing the test to the results of univariate
tests. The MSSET has consistently detected more SSE than the univariate tests.
[Table 2 about here.]
5. Discussion
In this paper, we have proposed a rigorous score test for studying overall evidence of SSE in
MMA. To the best of our knowledge, the proposed test is the first effort to study SSE in an
MMA setting. It can be thought of a multivariate extension of Egger’s regression test, which
naturally is Egger’s test when the number of outcomes is one (i.e., J = 1). For more general
settings (J > 2), the proposed test has the following advantageous properties, besides its
simplicity. First, by combining signals of SSE across multiple outcomes (whether or not they
are of different data types or on different scales), the proposed test can quantify SSE under
different scenarios, and is consistently more powerful than univariate tests. Second, by jointly
modeling multiple outcomes, the score test can fully account for the multivariate nature of
MMA, which avoids the need of a Bonferroni correction for multiple testing. As a technique
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and practical advantage, the within-study correlations are not required in the proposed test,
while the between-study correlations are properly accounted for in the testing procedure, by
the theory of composite likelihood.
ORB had not received sufficient attention until recently. Dwan et al. (2013) reviewed
the evidence from empirical cohort studies assessing ORB and showed that statistically
significant outcomes are more likely to be selectively reported. Copas et al. (2014) suggested
a likelihood-based model that reflects the empirical findings to estimate the severity of ORB.
More recently, Frosi et al. (2015) suggested that the difference between the results from
MMA and those from univariate meta-analysis indicates the presence of ORB. Designing
a specific test for detecting ORB is a topic of future research. In addition, to the best of
our knowledge, there is no literature investigating the relationship between ORB and study
sizes. This question is critical and deserves future investigation.
In this paper, we construct a composite likelihood under a working independence assump-
tion. It is worth mentioning that in some clinical trials, the measurement of secondary
outcomes is not of quality comparable to the measurement of a primary outcome, so it
is possible that when simply adding the two marginals together to form the composite
likelihood, the uncertainty contained in the low-quality secondary/exploratory outcomes can
dilute the information provided by the primary outcome.
One major motivation of the proposed method is that it does not require the knowledge
of within-study correlations under the working independence assumption. However, it is
of interest to investigate how within-study correlation affects the power in the scenario
where the within-study correction is available. We have conducted additional simulation
studies with results in Appendix H of the Supporting Information. We observed that the
full-likelihood based score test (FLST) with known within-study correlations tends to have
inflated Type I error rates when number of studies are relatively small (n < 50). A possible
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reason is that the model complexity is increased by introducing more correlation parameters.
On the other hand, the proposed model under the working independence assumption retains
the model parsimony by avoiding estimating the within-study correlation parameters. A full
investigation of the FLST and the development of methods to correct its small-sample bias
will be a future topic of interest.
The choice of numbers of outcome is an essential question in the multivariate meta-
analysis. A unified protocol is usually developed by the investigator team, where outcomes
of interests (multiple outcomes) are pre-specified. The choice of the multiple outcomes is
usually developed through discussions among clinicians and systematic reviewers based
on their clinical knowledge. For example, in an investigation of heart failure the multiple
outcomes could include all-cause mortality, heart failure related hospitalization, health-
related quality of in the protocol. Studies do not report those outcomes (but with these
outcomes in their protocols) may be subject to outcome reporting bias. In addition, one
advantage of the proposed method is under the working independence assumption it is doable
for many outcomes without introducing more correlation parameters, thus retains the model
parsimony and simplicity. It would be of interest to investigate the empirical performance of
the proposed test in settings with more than two outcomes.
One limitation of the proposed method is the asymptotic test distribution holds only
when number of studies are at least moderately large. Based on our simulation studies, the
number of studies should be greater than or equal to 10 to guarantee a good performance of
the proposed method. The use of the asymptotic distribution in settings where the number
of studies in a meta-analysis is small needs more investigation. Theory such as high order
asymptotics could be applied here to enhance the small sample performance of the proposed
test. Another limitation of the proposed method is that it only detects for SSE and does not
correct for it. An important extension is to develop a robust procedure to correct for SSE
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by jointly analyzing multivariate outcomes. Another interesting extension of the proposed
test is to network meta-analysis, where multiple treatments are compared jointly in clinical
trials but each trial may compare only a subset of all treatments. In addition, a common
limitation of the Egger’s regression test and its extensions is they only account for the shape
of deviates (skewness). Following a similar strategy as in Lin and Chu (2018), an interesting
future topic is to extend the proposed multivariate test based on skewness or kurtosis and
other distribution test.
To summarize, we have developed a simple and useful test to detect SSE in a multivariate
meta-analysis setting. As a natural extension of the univariate Egger’s regression test, our
test has the advantage of combining signals across outcomes without requiring within-study
correlations. We have found that the proposed test is substantially more powerful than the
univariate tests and has a practical impact on real applications, calling for more attention
on potential SSE or PB during research synthesis. We believe this test is a useful addition
for tackling the problem of SSE and PB in comparative effectiveness research.
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Figure 1. Funnel plots for Case study 1 in Section 4.1 (upper panels) and Case study 2
in Section 4.2 (lower panels).
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Figure 2. Probability of being published under Scenarios C1, C2, C3, and P. In Scenarios
C1-C3, the probabilities are shaded from dark to light (i.e., the largest probability refers to
the darkest shade). This figure appears in color in the electronic version of this article, and
any mention of color refers to that version.
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Figure 3. Power plots of the proposed MSSET test, Egger’s regression test on one outcome
(Egger1), and Egger’s regression test on two outcomes with Bonferroni correction (EggerBON)
and Benjamini & Hochberg correction (EggerBH) at the 10% nominal level for sample sizes
varying from 25 to 100 and between-study variances varying from 0.25 to 5. This figure
appears in color in the electronic version of this article, and any mention of color refers to
that version.
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Table 1
Type I error rates (×100%), at the 10% nominal level, of Egger’s test (E), Begg’s test(B), and the proposed MSSET
test. The univariate tests are conducted on the first outcome only, denoted as “test1”, and the p value adjustment
methods proposed by Bonferroni correction (bon), Holm, Hochberg (hoch), Benjamini & Hochberg (bh), Benjamini &
Yekutieli (by) are used to combine the test results, denoted as “test”. The number of studies n is 10, 25, 50, 75, and
100, and the between-study heterogeneity τ2 is 0.1, 0.9, and 1.9.
n τ 2 MSSET E1 Ebon Eholm Ehoch Ebh Eby B1 Bbon Bholm Bhoch Bbh Bby
10 0.1 12.9 14.7 15.8 8.7 9.0 9.0 6.6 2.4 2.1 1.1 1.1 1.1 0.4
0.9 12.7 13.2 14.6 8.1 8.4 8.4 6.3 2.6 2.0 1.0 1.1 1.1 0.4
1.9 11.9 13.1 15.0 8.2 8.4 8.4 6.3 2.3 1.6 0.8 0.9 0.9 0.3
25 0.1 11.3 11.9 13.0 7.0 7.3 7.3 5.1 17.8 22.4 12.6 13.0 13.0 10.4
0.9 11.1 11.4 12.2 6.6 6.9 6.9 4.7 24.1 32.7 18.8 19.1 19.1 16.3
1.9 10.9 11.3 12.0 6.5 6.9 6.9 4.3 24.6 33.7 19.4 19.8 19.8 17.0
50 0.1 10.4 10.7 10.9 5.9 6.2 6.2 4.2 38.1 51.8 32.8 33.3 33.3 29.2
0.9 10.5 10.8 10.6 5.7 6.0 6.0 3.9 44.7 61.7 40.9 41.5 41.5 37.2
1.9 10.4 10.9 10.6 5.7 6.0 6.0 3.8 45.5 62.8 41.9 42.4 42.4 38.4
75 0.1 10.0 9.8 9.8 5.3 5.6 5.6 3.5 48.2 65.5 44.3 44.8 44.8 40.4
0.9 10.3 10.2 9.8 5.4 5.8 5.8 3.8 55.9 73.8 52.3 52.7 52.7 48.7
1.9 10.1 10.5 10.2 5.6 5.9 5.9 3.8 56.6 74.8 53.4 53.8 53.8 49.6
100 0.1 9.9 9.9 9.6 5.2 5.5 5.5 3.7 55.4 72.1 50.3 50.9 50.9 46.7
0.9 9.7 9.8 9.7 5.3 5.5 5.5 3.6 62.0 79.8 57.8 58.3 58.3 54.2
1.9 9.7 10.2 9.6 5.1 5.4 5.4 3.4 63.0 80.7 58.9 59.4 59.4 55.5
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Table 2
Contingency table of MSSET test vs. Egger’s regression based on outcome 1 (Egger1) only and outcome 2 only
(Egger2), and Egger test using Bonferroni correction to combine the results from Egger’s test of bivariate outcomes
(EggerBonferroni) (i.e., S=1 if p-value < 0.1; S=0 if p-value > 0.1).
Egger1 Egger2 EggerBonferroni
MSSET S=0 S=1 S=0 S=1 S=0 S=1
S=0 31 3 31 3 31 3
S=1 6 1 6 1 4 3
